On Monday, Bristol-Myers Squibb Co (NYSE: BMY) was 1.70% up from the session before settling in for the closing price of $58.95. A 52-week range for BMY has been $39.35 – $61.10.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 17.18%. When this article was written, the company’s average yearly earnings per share was at -87.79%. With a float of $2.03 billion, this company’s outstanding shares have now reached $2.03 billion.
Considering the fact that the conglomerate employs 34100 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 70.41%, operating margin of 21.74%, and the pretax margin is -14.5%.
Bristol-Myers Squibb Co (BMY) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Bristol-Myers Squibb Co stocks. The insider ownership of Bristol-Myers Squibb Co is 0.09%, while institutional ownership is 77.62%. The most recent insider transaction that took place on Nov 04 ’24, was worth 38,930. In this transaction SVP and Controller of this company sold 700 shares at a rate of $55.62, taking the stock ownership to the 11,760 shares. Before that another transaction happened on Nov 01 ’24, when Company’s EVP,Chief Med.Offr.,Drug Dev. bought 1,830 for $54.67, making the entire transaction worth $100,055. This insider now owns 62,109 shares in total.
Bristol-Myers Squibb Co (BMY) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -87.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.95% during the next five years compared to 5.14% growth over the previous five years of trading.
Bristol-Myers Squibb Co (NYSE: BMY) Trading Performance Indicators
You can see what Bristol-Myers Squibb Co (BMY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.56. Likewise, its price to free cash flow for the trailing twelve months is 8.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.60, a number that is poised to hit 1.47 in the next quarter and is forecasted to reach 6.93 in one year’s time.
Technical Analysis of Bristol-Myers Squibb Co (BMY)
Compared to the last year’s volume of 9.93 million, its volume of 9.89 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 66.87%. Additionally, its Average True Range was 1.28.
During the past 100 days, Bristol-Myers Squibb Co’s (BMY) raw stochastic average was set at 91.38%, which indicates a significant increase from 80.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.69% in the past 14 days, which was lower than the 27.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $57.73, while its 200-day Moving Average is $49.99. Nevertheless, the first resistance level for the watch stands at $60.66 in the near term. At $61.36, the stock is likely to face the second major resistance level. The third major resistance level sits at $62.42. If the price goes on to break the first support level at $58.90, it is likely to go to the next support level at $57.84. Now, if the price goes above the second support level, the third support stands at $57.14.
Bristol-Myers Squibb Co (NYSE: BMY) Key Stats
There are 2,028,177K outstanding shares of the company, which has a market capitalization of 121.59 billion. As of now, sales total 45,006 M while income totals 8,025 M. Its latest quarter income was 11,892 M while its last quarter net income were 1,211 M.
